Abstract: The systems, methods, apparatuses, and articles disclosed herein provide a new approach to treatment symptoms, such as proprioceptive dysfunction and vestibular disorders, which may be caused by certain types of human ailments. According to the present disclosure, a wearable article may include one or more limb sections and a resilient member may be provided along a length of each of the one or more limb sections and configured to generate a resistance force. Adjustments to the resistance force provided by the resilient member(s) may be adjusted using cord locks. As a user wearing the wearable article moves, the resistance force is applied to the user's limbs. Strain gauges may be provided to measure the resistance force(s), which enables verification that the resilient members are sized and configured to provide an appropriate amount of resistance force to a user and may improve programs and regimens designed to treat such ailments.

Abstract: Described herein are glass forming apparatuses with cooled muffle assemblies and methods for using the same to form glass ribbons. According to one embodiment, a muffle assembly for a fusion forming apparatus may include a muffle frame comprising a back wall, a front wall opposite the back wall, and a pair of sidewalls joining the front wall to the back wall in a closed-loop. At least one first cooling tube may extend through the back wall and the front wall across the closed-loop. At least one second cooling tube may extend through the back wall and the front wall across the closed loop such that the at least one second cooling tube is spaced apart from and parallel with the at least one first cooling tube.

Abstract: The systems, methods, apparatuses, and articles disclosed herein provide a new approach to treatment symptoms, such as proprioceptive dysfunction and vestibular disorders, which may be caused by certain types of human ailments. According to the present disclosure, a wearable article may include one or more limb sections and a resilient member may be provided along a length of each of the one or more limb sections and configured to generate a resistance force. Adjustments to the resistance force provided by the resilient member(s) may be adjusted using cord locks. As a user wearing the wearable article moves, the resistance force is applied to the user's limbs. Strain gauges may be provided to measure the resistance force(s), which enables verification that the resilient members are sized and configured to provide an appropriate amount of resistance force to a user and may improve programs and regimens designed to treat such ailments.

Abstract: The systems, methods, apparatuses, and articles disclosed herein provide a new approach to treatment symptoms, such as proprioceptive dysfunction and vestibular disorders, which may be caused by certain types of human ailments. According to the present disclosure, a wearable article may include one or more limb sections and a resilient member may be provided along a length of each of the one or more limb sections and configured to generate a resistance force. Adjustments to the resistance force provided by the resilient member(s) may be adjusted using cord locks. As a user wearing the wearable article moves, the resistance force is applied to the user's limbs. Strain gauges may be provided to measure the resistance force(s), which enables verification that the resilient members are sized and configured to provide an appropriate amount of resistance force to a user and may improve programs and regimens designed to treat such ailments.

Abstract: The systems, methods, apparatuses, and articles disclosed herein provide a new approach to treatment symptoms, such as proprioceptive dysfunction and vestibular disorders, which may be caused by certain types of human ailments. According to the present disclosure, a wearable article may include one or more limb sections and a resilient member may be provided along a length of each of the one or more limb sections and configured to generate a resistance force. Adjustments to the resistance force provided by the resilient member(s) may be adjusted using cord locks. As a user wearing the wearable article moves, the resistance force is applied to the user's limbs. Strain gauges may be provided to measure the resistance force(s), which enables verification that the resilient members are sized and configured to provide an appropriate amount of resistance force to a user and may improve programs and regimens designed to treat such ailments.

Abstract: Described herein are glass forming apparatuses with cooled muffle assemblies and methods for using the same to form glass ribbons. According to one embodiment, a muffle assembly for a fusion forming apparatus may include a muffle frame comprising a back wall, a front wall opposite the back wall, and a pair of sidewalls joining the front wall to the back wall in a closed-loop. At least one first cooling tube may extend through the back wall and the front wall across the closed-loop. At least one second cooling tube may extend through the back wall and the front wall across the closed loop such that the at least one second cooling tube is spaced apart from and parallel with the at least one first cooling tube.

Abstract: Described herein are glass forming apparatuses with cooled muffle assemblies and methods for using the same to form glass ribbons. According to one embodiment, a muffle assembly for a fusion forming apparatus may include a muffle frame comprising a back wall, a front wall opposite the back wall, and a pair of sidewalls joining the front wall to the back wall in a closed-loop. At least one first cooling tube may extend through the back wall and the front wall across the closed-loop. At least one second cooling tube may extend through the back wall and the front wall across the closed loop such that the at least one second cooling tube is spaced apart from and parallel with the at least one first cooling tube.

Abstract: Described herein are glass forming apparatuses with cooled muffle assemblies and methods for using the same to form glass ribbons. According to one embodiment, a muffle assembly for a fusion forming apparatus may include a muffle frame comprising a back wall, a front wall opposite the back wall, and a pair of sidewalls joining the front wall to the back wall in a closed-loop. At least one first cooling tube may extend through the back wall and the front wall across the closed-loop. At least one second cooling tube may extend through the back wall and the front wall across the closed loop such that the at least one second cooling tube is spaced apart from and parallel with the at least one first cooling tube.

Abstract: The present invention relates to a pharmaceutical composition when used for inhibiting a herpesviridae infection and/or providing relief from a herpesviridae infection in a subject. The composition includes an effective amount of an extract from a plant in the Asteraceae family.

Abstract: A liquid core and shell product is provided. The product can have at least three layers: a solid food based material, a liquid-based substance, and an encapsulate material. The liquid core and shell product can deliver a liquid-based substance to the mouth of a consumer in a clean way, where it may also provide a unique mouth feel. The liquid core and shell product can also act as a delivery vehicle for functional ingredients and/or organoleptic enhancers.

Abstract: The present invention relates to a pharmaceutical composition when used for inhibiting a herpesviridae infection and/or providing relief from a herpesviridae infection in a subject. The composition includes an effective amount of an extract from a plant in the Asteraceae family.

Abstract: A liquid core and shell product is provided. The product can have at least three layers: a solid food based material, a liquid-based substance, and an encapsulate material. The liquid core and shell product can deliver a liquid-based substance to the mouth of a consumer in a clean way, where it may also provide a unique mouth feel. The liquid core and shell product can also act as a delivery vehicle for functional ingredients and/or organoleptic enhancers.

Abstract: The present invention relates to a pharmaceutical composition when used for inhibiting a herpesviridae infection and/or providing relief from a herpesviridae infection in a subject. The composition includes an effective amount of an extract from a plant in the Asteraceae family.

Abstract: The present invention relates to a pharmaceutical composition when used for inhibiting a herpesviridae infection and/or providing relief from a herpesvindae infection in a subject. The composition includes an effective amount of an extract from a plant in the Asteraceae family.

Abstract: The present invention relates to animal chews and, in particular, to dog chews, which have a long lasting time. More specifically, the present invention provides use of gelatinized starch for the purpose of increasing the lasting time of an animal chew.